GLAXOSMITH ended its 2021FY financial period on a positive note as its topline surged moderately by 5.42%YoY to NGN22.45bn (from NGN21.30bn in 2020FY). The topline expansion was spearheaded by growth in the Consumer Healthcare segment (+16.63%YoY) while the Pharmaceuticals Segment grew by 0.77%YoY to NGN15.16bn (vs NGN15.05bn in 2020FY). Hence, revenue stood at NGN22.45bn in 2021FY compared to NGN21.30bn in the previous financial period. In the first quarter of 2022, the firm also recorded an impressive expansion in topline. We note that the revenue performance in the quarter represents its highest quarterly revenue in 24 quarters (since Q1:2016).
You May Also Like
Daily Stock Market Update for 8th July, 2021
- July 8, 2021
kindly find attached, daily stock Daily Stock Market Report for 8th July 2021market update for 8th July, 2021
Daily Market Report – 15th March 2022
- March 22, 2022
Dear All, Kindly click the link below to access our stock market report for today, March 15, 2022.…
Week in View – January 29th, 2021
- January 30, 2021
Following last week’s bearish outing, the Nigerian equities market closed on a positive note this week as the…
Earnings Update- CADBURY- H1:2021
- August 25, 2021
Kindly find the link below for CADBURY’s earnings update for H1:2021. Regards,Earnings Update- CADBURY- H1-2021.
Earnings Update – DANGCEM 2021FY Staying on the Path of Growth
- April 8, 2022
Nothing takes us by surprise in the just released 2021FY financial scorecard of Dangote Cement Plc. Revenue performance…
Equity Commentary- September 2021
- September 28, 2021
The domestic economy is gradually recovering from last year’s recession, with real GDP growth rate of 0.51% and…